Collectively, these findings demonstrate that BF exerts potent antitumor effects in orthotopic HCC through the inhibition of EGFR-mediated RAS/RAF/MEK/ERK signaling cascade activation. The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.